MRIガイド下神経外科アブレーションの市場規模、シェア、成長分析、製品別、適応症別、最終用途別、地域別 - 産業予測、2025年～2032年

MRIガイド下神経外科アブレーション2023年の市場規模は5億9,000万米ドルで、2024年の6億3,543万米ドルから2032年には11億5,025万米ドルに拡大し、予測期間（2025年～2032年）のCAGRは7.7％で成長する見通しです。

神経外科市場は、低侵襲手術技術へのシフトとともに、神経系疾患や脳腫瘍の増加によって大きく拡大しています。特殊な機器によって組織の損傷や手術のリスクを最小限に抑えるこれらの高度な手術は、回復までの時間が早く、切開の回数が少ないため、患者に好まれています。MRIを利用して腫瘍を正確に破壊するUCLで開発された新しいがん治療のような技術革新は、健康な組織を傷つけることなく治療効果をさらに高めています。さらに、高解像度MRI技術の進歩は、手術中のリアルタイムの可視化を可能にし、安全性と患者の転帰を向上させています。米国がん協会は、2023年に脳および神経系のがんが新たに24,810例近く発生すると予測しており、このような侵襲性の低い治療に対する需要は今後も増加し続けると思われます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 主要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ

MRIガイド下神経外科アブレーションの市場規模：製品別 & CAGR（2025年～2032年）

• 市場概要
• MRI誘導レーザーアブレーションシステム
• MRI誘導RFアブレーションシステム
• MRI誘導集束超音波システム
• アクセサリー

MRIガイド下神経外科アブレーションの市場規模：適応症別 & CAGR（2025年～2032年）

• 市場概要
• 腫瘍
• てんかん
• 疼痛管理
• 血管奇形

MRIガイド下神経外科アブレーションの市場規模：最終用途別 & CAGR（2025年～2032年）

• 市場概要
• 病院
• クリニック
• 外来手術センター

MRIガイド下神経外科アブレーションの市場規模 & CAGR（2025年～2032年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022年～2024年）

主要企業プロファイル

• Monteris Medical（米国）
• InSightec Ltd.（イスラエル）
• Profound Medical Corp.（カナダ）
• Medtronic plc（アイルランド）
• Boston Scientific Corporation（米国）
• AngioDynamics Inc.（米国）
• ClearPoint Neuro, Inc.（米国）
• Elekta AB（スウェーデン）
• Accuray Incorporated（米国）
• Brainlab AG（ドイツ）
• Varian Medical Systems（米国）
• Abbott Laboratories（米国）
• Siemens Healthineers AG（ドイツ）
• Philips Healthcare（オランダ）
• GE Healthcare（米国）

結論と提言

MRI-Guided Neurosurgical Ablation Market size was valued at USD 590.0 million in 2023 and is poised to grow from USD 635.43 million in 2024 to USD 1150.25 million by 2032, growing at a CAGR of 7.7% during the forecast period (2025-2032).

The market for neurosurgery is expanding significantly, driven by an increase in nervous system disorders and brain tumors, alongside a shift toward minimally invasive surgical techniques. These advanced procedures, which minimize tissue injury and surgical risks through specialized equipment, are preferred by patients due to their expedited recovery times and fewer incisions. Innovations, such as a new cancer treatment developed at UCL that utilizes MRI for precise tumor destruction, are further enhancing treatment efficacy without harming healthy tissue. Additionally, advancements in high-resolution MRI technology enable real-time visualization during surgeries, improving safety and patient outcomes. As the American Cancer Society projects nearly 24,810 new cases of brain and nervous system cancers in 2023, the demand for these less invasive treatments will continue to rise.

Top-down and bottom-up approaches were used to estimate and validate the size of the Mri-Guided Neurosurgical Ablation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Mri-Guided Neurosurgical Ablation Market Segments Analysis

Global MRI-Guided Neurosurgical Ablation Market is segmented by Product, Indication, End-Use and region. Based on Product, the market is segmented into MRI Guided Laser Ablation Systems, MRI Guided RF Ablation Systems, MRI Guided Focused Ultrasound Systems and Accessories. Based on Indication, the market is segmented into Tumors, Epilepsy, Pain Management and Vascular Malformations. Based on End-Use, the market is segmented into Hospitals, Clinics and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Mri-Guided Neurosurgical Ablation Market

The MRI-Guided Neurosurgical Ablation market is primarily fueled by the rising incidence of neurological disorders. These conditions, which significantly affect the nervous system, often lead to severe or even life-threatening consequences for patients. As such, there is an escalating need for effective treatment options. Innovative therapies, particularly MRI-guided neurosurgical ablation, have gained traction due to their precision and effectiveness in treating complex neurological issues. This growing acceptance of advanced, minimally invasive techniques represents a pivotal shift in the management of neurological diseases, further driving the market demand for MRI-guided neurosurgical ablation solutions.

Restraints in the Mri-Guided Neurosurgical Ablation Market

The MRI-guided neurosurgical ablation market faces significant restraints primarily due to insurance and reimbursement challenges. Although these innovative procedures provide promising treatment options for patients with neurological disorders, inconsistencies in insurance coverage and reimbursement policies can create substantial financial barriers. Many insurance providers may not offer comprehensive coverage for MRI-guided neurosurgical ablation, resulting in patients having to pay a considerable portion of the costs themselves, which may deter them from pursuing these treatments. Furthermore, the absence of standardized reimbursement protocols across different regions and insurance plans exacerbates these financial challenges, leading to varied access for patients and potentially hindering the widespread adoption of this advanced technology. Addressing these issues is essential to facilitate fair access to MRI-guided neurosurgical ablation and encourage its integration into standard healthcare practices.

Market Trends of the Mri-Guided Neurosurgical Ablation Market

The MRI-guided neurosurgical ablation market is witnessing a significant shift towards patient-centric care, which is revolutionizing treatment paradigms by prioritizing individual patient needs and preferences. This trend underscores the importance of tailoring procedures to match specific patient conditions, enhancing the effectiveness of minimally invasive treatments. By fostering collaborative decision-making, patients become active participants in their healthcare journey, leading to improved satisfaction and outcomes. As this patient-centered model gains momentum, it aligns with the broader movement towards personalized and responsive healthcare services in neurosurgery, thereby positioning MRI-guided ablation as a cornerstone of modern, individualized patient care solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global MRI-Guided Neurosurgical Ablation Market Size by Product & CAGR (2025-2032)

• Market Overview
• MRI Guided Laser Ablation Systems
• MRI Guided RF Ablation Systems
• MRI Guided Focused Ultrasound Systems
• Accessories

Global MRI-Guided Neurosurgical Ablation Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Tumors
• Epilepsy
• Pain Management
• Vascular Malformations

Global MRI-Guided Neurosurgical Ablation Market Size by End-Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Clinics
• Ambulatory Surgical Centers

Global MRI-Guided Neurosurgical Ablation Market Size & CAGR (2025-2032)

• North America (Product, Indication, End-Use)
  • US
  • Canada
• Europe (Product, Indication, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Indication, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Indication, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Indication, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Monteris Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InSightec Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Profound Medical Corp. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ClearPoint Neuro, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elekta AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accuray Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brainlab AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Varian Medical Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations